Blue Cloud Softech Solutions Ltd Announces Strategic Acquisition of Global Impex Inc. from ConnectM Technology Solutions, Inc.

Blue Cloud Softech Solutions Ltd (BCSSL) has announced the board-approved acquisition of 100 per cent of Global Impex Inc (GIX) from the U.S.-based ConnectM Technology Solutions, Inc. This strategic move aims to establish a scalable "Blue Energy" platform, integrating clean energy solutions for data centres, industrial sectors, and electric mobility. The transaction will be executed via an all-equity share swap, expected to conclude within six to nine months pending regulatory, shareholder, and due diligence approvals.

The acquisition brings a robust portfolio of tangible and intangible assets into BCSSL’s ecosystem, including electric mobility solutions, rooftop Solar businesses, and distributed microgrids. Furthermore, GIX provides BCSSL with exclusive Indian licenses for proprietary technologies developed by ConnectM and Keen Labs. These include advanced systems for virtual power plants (VPPs) and AI-driven energy management, which BCSSL intends to leverage for its upcoming AI-enabled data center projects and broader infrastructure expansion.

Strategically, this consolidation allows BCSSL to accelerate the deployment of climate-tech solutions by utilising its existing relationships with the government and telecom sectors. By housing these assets under a dedicated Blue Energy vertical, the company plans to attract long-term institutional capital and scale its EV and energy storage operations. Meanwhile, the deal enables ConnectM to simplify its structure and focus on the U.S. market while maintaining a significant stake in India’s growing energy sector through its new equity position in BCSSL.

About the Company

Founded in 1991, Blue Cloud Softech Solutions Ltd. is a BSE-listed technology and infrastructure solutions company with over three decades of execution experience across India and international markets. BCSSL operates through high-growth verticals, including digital health (BluHealth), AI diagnostics (BluBio), advanced sterilisation (BioSter), 5G FWA, cybersecurity, and enterprise telecom, supported by a structured SPV-based governance framework.

Revenue for the nine months surged to Rs 723.38 crore, a substantial leap from Rs 613.24 crore in the previous year. More importantly, the company demonstrated high operational leverage; while revenue grew steadily, EBITDA jumped from Rs 51.63 crore to Rs 77.57 crore and Profit After Tax (PAT) for the nine months spiked by nearly 55 per cent to reach Rs 48.39 crore. This trend of increasing profitability and expanding margins suggests that BCSSL is successfully scaling its AI and cybersecurity offerings with high efficiency.

The stock is up by 53 per cent from its 52-week low of Rs 14.95 per share and has given multibagger returns of 360 per cent in 5 years. The company's shares have a PE ratio of 15x, an ROE of 45 per cent and an ROCE of 37 per cent. The company has a market cap of over Rs 1,600 crore and Promoters Bought a 3.93 per cent stake in the company in December 2025, compared to September 2025.

Disclaimer: The article is for informational purposes only and not investment advice.